2024’s Biggest AI Stories
Artificial Intelligence took the industry by storm this year, but how is actually being implemented?
Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences industry.
While no company has yet achieved the full promise of AI to radically accelerate time to market, meaningful strides are being made across the drug discovery funnel.
As AI continues to dominate the news, maximizing its potential is on every C-suite leader’s mind. Successful AI adoption, specifically in HCP marketing, will require a thoughtful, customer-centric approach to avoid aggravating the promotional fatigue and dissatisfaction fostered by drugmakers' dash toward digital1 since COVID-19. This article provides an overview of some key areas for AI integration that can help improve the HCP customer experience today and tomorrow.
The Astellas chief commercial officer discusses the impact that the increase in global and local connectivity has had on commercialization, among other trends.
EVERSANA’s chief digital officer discusses the current relationship between pharma and AI.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
